ROSSI, MADDALENA
 Distribuzione geografica
Continente #
AS - Asia 1.938
NA - Nord America 1.717
EU - Europa 1.593
SA - Sud America 234
AF - Africa 72
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.560
Nazione #
US - Stati Uniti d'America 1.637
IT - Italia 763
SG - Singapore 725
CN - Cina 454
VN - Vietnam 170
BR - Brasile 166
HK - Hong Kong 136
BD - Bangladesh 132
KR - Corea 127
GB - Regno Unito 125
DE - Germania 122
FR - Francia 108
NL - Olanda 95
FI - Finlandia 72
PL - Polonia 56
SE - Svezia 52
RU - Federazione Russa 51
IN - India 48
CA - Canada 37
MA - Marocco 31
JP - Giappone 28
CH - Svizzera 27
IE - Irlanda 21
MX - Messico 21
AT - Austria 20
TR - Turchia 18
ZA - Sudafrica 18
IQ - Iraq 16
AR - Argentina 13
GR - Grecia 12
ID - Indonesia 11
PT - Portogallo 11
PY - Paraguay 11
CL - Cile 10
EC - Ecuador 10
PK - Pakistan 10
ES - Italia 9
EG - Egitto 8
PE - Perù 7
SA - Arabia Saudita 7
TW - Taiwan 7
UA - Ucraina 7
CO - Colombia 6
MY - Malesia 6
BE - Belgio 5
BG - Bulgaria 5
DZ - Algeria 5
PH - Filippine 5
CR - Costa Rica 4
IR - Iran 4
NP - Nepal 4
PA - Panama 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
BO - Bolivia 3
CZ - Repubblica Ceca 3
IL - Israele 3
IS - Islanda 3
JO - Giordania 3
LV - Lettonia 3
NO - Norvegia 3
RS - Serbia 3
SN - Senegal 3
UY - Uruguay 3
AZ - Azerbaigian 2
BF - Burkina Faso 2
BH - Bahrain 2
BY - Bielorussia 2
BZ - Belize 2
GE - Georgia 2
HR - Croazia 2
JM - Giamaica 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LT - Lituania 2
QA - Qatar 2
RO - Romania 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
SV - El Salvador 2
UZ - Uzbekistan 2
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
CG - Congo 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
KG - Kirghizistan 1
KI - Kiribati 1
KW - Kuwait 1
LU - Lussemburgo 1
MN - Mongolia 1
MQ - Martinica 1
Totale 5.550
Città #
Singapore 380
Ashburn 295
San Jose 214
Hefei 170
Hong Kong 132
Seoul 124
Trieste 91
Milan 89
Beijing 83
Council Bluffs 74
Chandler 71
Dallas 68
London 67
Boardman 66
Ho Chi Minh City 62
Los Angeles 59
Chicago 54
Helsinki 54
Rome 53
Santa Clara 52
New York 48
Hanoi 42
Lauterbourg 37
Munich 37
Frankfurt am Main 32
Zgierz 32
Buffalo 26
Casablanca 25
São Paulo 25
Columbus 24
Dublin 21
The Dalles 21
Moscow 18
Amsterdam 16
Bologna 16
Orem 16
Bern 15
Naples 15
Seattle 15
Warsaw 14
Boydton 13
Montreal 13
Brooklyn 12
Venice 12
Verona 12
Vienna 12
Florence 11
Parma 11
Toronto 11
Palermo 10
Tokyo 10
Washington 10
Athens 9
Da Nang 9
Johannesburg 9
Reggio Emilia 9
Turku 9
Cleveland 8
Denver 8
Düsseldorf 8
Houston 8
Lappeenranta 8
Nuremberg 8
Poplar 8
Redondo Beach 8
San Francisco 8
Santiago 8
Turin 8
Wuhan 8
Casamassima 7
Istanbul 7
Mumbai 7
Roubaix 7
Shanghai 7
Udine 7
Buja 6
Chennai 6
Curitiba 6
Dhaka 6
Manchester 6
Rio de Janeiro 6
Salt Lake City 6
Taranto 6
Wroclaw 6
Ancona 5
Atlanta 5
Boston 5
Brescia 5
Brussels 5
Davos 5
Guangzhou 5
Kuala Lumpur 5
Lahore 5
Marburg 5
Memphis 5
Mexico City 5
Paris 5
Sofia 5
Baghdad 4
Bari 4
Totale 3.205
Nome #
I dieci punti che il cardiologo deve conoscere su scintigrafia miocardica con traccianti ossei, amiloidosi e cuore 370
Prevalence and prognostic significance of ischemic late gadolinium enhancement pattern in non-ischemic dilated cardiomyopathy 233
Prevalence and evolution of right ventricular dysfunction among different genetic backgrounds in dilated cardiomyopathy 219
Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis 210
Evolving trends in epidemiology and natural history of cardiac amyloidosis: 30-year experience from a tertiary referral center for cardiomyopathies 183
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 177
Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy 175
Radiologia cardiovascolare. 70 anni di immagini dall’“Archivio Camerini” ai giorni nostri 171
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey 170
Grey zones in the supportive treatments of cardiac amyloidosis 166
Tafamidis in the Treatment of ATTR-related Cardiomyopathy: Indications and Grey Zones 165
COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy? 154
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 153
Prognostic value of cardiopulmonary exercise testing repetition during follow-up of clinically stable patients with severe dilated cardiomyopathy. A preliminary study 152
Critical analysis of the 2023 ESC guidelines on cardiomyopathy management 151
A matter of sex-persistent predictive value of MECKI score prognostic power in men and women with heart failure and reduced ejection fraction: a multicenter study 147
Che cos’è l’Amiloidosi? 143
Integrating pulmonary function testing with cardiopulmonary exercise testing for enhanced stratification in hypertrophic cardiomyopathy 138
Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis 138
Re-Definition of the Epidemiology of Cardiac Amyloidosis 135
Abnormal conduction-induced cardiomyopathy: a poorly explored entity 131
11.2. DVS, IC [Cardio-oncologia] 130
Conoscere e Curare il Cuore 2024 - Le cardiomiopatie da disturbo di conduzione 130
Sport and Exercise in Genotype positive (+) Phenotype negative (-) Individuals. Current Dilemmas and Future Perspectives 124
Oxygen Uptake Efficiency Slope at a Glance: A Fascinating Index Carrying Unsolved Questions 116
Fenotypic expressions and clinical manifestations of arrhythmogenic cardiomyopathy 116
Implementation of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction (OpTIMa-HF Registry) 116
Aficamten in non-obstructive hypertrophic cardiomyopathy: Unlocking new horizons? 113
New perspectives in diagnosis and risk stratification of non-ischaemic dilated cardiomyopathy 110
Pianeta Cuore 3.0 istruzioni per conoscerlo e mantenerlo sano 110
Light-chain cardiac amyloidosis: a case report of extraordinary sustained pathological response to cyclophosphamide, bortezomib, and dexamethasone combined therapy 109
Cardiomiopatie a esordio acuto 107
Unveiling the limitations of non-metabolic thresholds in assessing maximal effort: The role of cardiopulmonary exercise testing 103
Value of the HFA-PEFF and H2 FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 96
Clustering in dilated cardiomyopathy at initial evaluation: An effective tool for clinical stratification 91
Management of hypertrophic cardiomyopathy 88
e-ITALICA (enhanced ITAlian rainfall-induced LandslIdes CAtalogue) 79
Impact of glomerular filtration rate estimation formulas on MECKI score performance and prognostic accuracy in heart failure: the MECKI-RENAL study 74
Non-invasive stroke volume assessment during cardiopulmonary exercise testing provides additional insight beyond O2-pulse in hypertrophic cardiomyopathy 61
Applicabilità, performance e potenzialità prognostiche degli scores di rischio poligenico nella cardiomiopatia dilatativa: risultati da due centri europei di riferimento per le cardiomiopatie 56
Cardiopulmonary exercise testing in hypertrophic cardiomyopathy: the role of reduced O2 pulse and chronotropic incompetence in myocardial adaptation 54
RoMa: A Cardiopulmonary Exercise Testing Based Risk Tool in Hypertrophic Cardiomyopathy 9
Polygenic risk in early-onset coronary artery disease with low prevalence of traditional cardiovascular risk factors 6
null 1
Totale 5.680
Categoria #
all - tutte 16.500
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.500


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 0 1
2021/202244 0 2 4 9 2 5 4 1 2 1 6 8
2022/2023280 4 28 40 41 18 32 9 23 22 11 36 16
2023/2024529 40 31 34 55 35 33 77 52 12 22 59 79
2024/20251.360 59 75 169 87 113 76 100 84 119 178 118 182
2025/20263.458 322 272 314 332 260 247 373 152 360 392 274 160
Totale 5.680